In our study, miR-29-x was predicted to target the DETmR AP-1 complex subunit gamma-1 (AP1G1), which in mammals is known to affect HIV-1 infection by influencing the process of HIV-mediated CD4 internalization and targeting to lysosomes [56]. Here, CD4 is linked to HIV-1 infection.